Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
96 participants
INTERVENTIONAL
2016-12-31
2018-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Addressing Emotional and Cognitive Factors in Behavioral Weight Loss Treatment
NCT00533052
Acceptance Based Behavioral Intervention for Weight Loss: A Randomized Trial
NCT01461421
Weight Gain Prevention
NCT00606840
The Effects of a Weight Management Program on Body Weight and Quality of Life
NCT02219763
Brief Behavioral Weight Loss Treatment vs. Weight Watchers
NCT00249340
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
One strategy for doing so is to focus on the potential benefits of avoiding unhealthy choices. Health messaging studies suggest that messages focused on promoting long-term benefits of healthier choices may be effective in encouraging initiation of, or positive attitudes toward, healthy behaviors, however, longer-term effects of these messages have not been studied in the context of obesity. By contrast, behavioral economic work on Prospect Theory suggests focusing on preventing future negative consequences may be superior, and the threat of weight gain is a more powerful motivator than the benefit of weight loss. Although prevention strategies have been successfully employed in smoking cessation and anti-smoking campaigns, they are not typically used in obesity treatment. In promising preliminary neuroimaging work, the investigators identified increases in brain regions involved in inhibitory control and decreases in cravings when using this PREVENT strategy.
The goal of this R03 is to test whether an intervention built upon the goal to PREVENT long-term consequences of weight gain versus an intervention built upon the goal to PROMOTE long-term benefits of weight loss is beneficial in altering valuation of health and taste in food choice decision-making, encouraging adherence, reducing food cravings and consumption, and ultimate weight loss, as compared to a standard behavioral weight loss program (BWL). A total of 90 overweight/obese men and women will be randomly assigned to either PREVENT, PROMOTE, or standard BWL. Each intervention will have one in-person training session wherein participants will learn key strategies of their assigned program, and the remaining 12 weekly lessons will be delivered via internet. Baseline and 3-month (post-treatment) assessments will include the food choice decision-making task featured in the parent K01 to measure valuation of health and taste, weight measurement, and measurement of food cravings and consumption. To address feasibility, adherence and engagement measures (i.e., lessons viewed, self-monitoring) will be collected during the internet program, and memory for lesson content will be assessed post-treatment. Individual difference measures will also be collected to provide preliminary data on factors that may influence success in each arm.
This project tests innovative approaches in the clinical treatment of obesity and will provide new insights into the potential role of prevention versus promotion strategies for weight loss.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
STANDARD
12-week Internet-delivered behavioral weight loss program
STANDARD
Standard Internet-delivered behavioral weight loss
PREVENT
an enhanced 12-week Internet-delivered behavioral weight loss program focused on preventing future negative consequences
PREVENT
enhanced standard Internet-delivered behavioral weight loss program
PROMOTE
an enhanced 12-week Internet-delivered behavioral weight loss program focused on promoting future benefits
PROMOTE
enhanced standard Internet-delivered behavioral weight loss program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
STANDARD
Standard Internet-delivered behavioral weight loss
PREVENT
enhanced standard Internet-delivered behavioral weight loss program
PROMOTE
enhanced standard Internet-delivered behavioral weight loss program
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* currently overweight or obese (BMI 25-45 kg/m2)
Exclusion Criteria
* weight loss medications
* neurological or psychiatric conditions including but not limited to schizophrenia, and bipolar disorder
* inability to attend assessments
* lack of interest in participating in a behavioral weight loss trial
* serious current physical disease for which physician supervision of diet and exercise prescription is needed
* physical problems that limit the ability to exercise
* participation in a weight loss program within the last 2 months
* intention to become pregnant in the next 3 months
25 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Miriam Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kathryn E. Demos
Assistant Professor (Research)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.